DelNova
About:
DelNova is a therapeutics company that solves unmet medical needs.
Website: https://www.delnova.net
Description:
DelNova is developing proprietary therapies by leveraging advances in drug delivery technology. They have identified an anticholinesterase class of drugs as a means of accelerating muscle recovery by indirectly increasing the neurotransmitter deficit caused by botulinum toxin.
Total Funding Amount:
$810000
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Illinois City, Illinois, United States
Founded Date:
2016-01-01
Founders:
Mary Gardner
Number of Employees:
11-50
Last Funding Date:
2018-04-02
IPO Status:
Private
Industries:
© 2025 bioDAO.ai